日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Heat Shock Protein 70 Constitutes a Promising Novel Biomarker in Differential Diagnosis between Takotsubo Syndrome and Non-ST-Segment Elevation Myocardial Infarction

热休克蛋白 70 是一种有前途的新型生物标志物,可用于鉴别诊断 Takotsubo 综合征和非 ST 段抬高型心肌梗死

Ozan Demirel, Vera Paar, Philipp Tolnai, Albert Topf, Uta C Hoppe, Michael Lichtenauer, Moritz Mirna

Novel Biomarkers as Potential Predictors of Decompensated Advanced Chronic Heart Failure-Single Center Study

新型生物标志物作为失代偿性晚期慢性心力衰竭的潜在预测指标——单中心研究

Tobias Fröhling, Dilvin Semo, Moritz Mirna, Vera Paar, Zornitsa Shomanova, Lukas J Motloch, Andreas Rukosujew, Jürgen R Sindermann, Michael Lichtenauer, Rudin Pistulli

Insulin-like Growth Factor-Binding Protein 2 in Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Gender-Based Perspective

胰岛素样生长因子结合蛋白 2 在重度主动脉瓣狭窄和肺动脉高压中的作用:基于性别的视角

Elke Boxhammer, Vera Paar, Kristen Kopp, Sarah X Gharibeh, Evelyn Bovenkamp-Aberger, Richard Rezar, Michael Lichtenauer, Uta C Hoppe, Moritz Mirna

Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac Arrest

无细胞双链 DNA 与 DNase 比率可预测原发性心脏骤停后存活的结果

Richard Rezar, Michael Lichtenauer, Vera Paar, Adrienne Aszlan, Thomas M Hofbauer, Reinhard Kaufmann, Sarah Wernly, Clemens Seelmaier, Moritz Mirna, Andreas Mangold, Irene M Lang, Uta C Hoppe, Anna S Ondracek, Bernhard Wernly

The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome

特定心血管生物标志物对 Takotsubo 综合征的鉴别诊断价值

Albert Topf, Moritz Mirna, Vera Paar, Lukas J Motloch, Janine Grueninger, Christiane Dienhart, Paul C Schulze, Mathias C Brandt, Robert Larbig, Uta C Hoppe, Daniel Kretzschmar, Michael Lichtenauer

Differential Diagnosis between Takotsubo Syndrome and Acute Coronary Syndrome-A Prospective Analysis of Novel Cardiovascular Biomarkers for a More Selective Triage

Takotsubo 综合征与急性冠状动脉综合征的鉴别诊断 - 前瞻性分析新型心血管生物标志物以实现更具选择性的分类

Albert Topf, Moritz Mirna, Vera Paar, Lukas J Motloch, Nina Bacher, Marcus Franz, Uta C Hoppe, Daniel Kretzschmar, Michael Lichtenauer

Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?

可溶性 ST2 是否可以作为 TAVR 患者肺动脉高压风险评估的潜在生物标志物?

Elke Boxhammer, Moritz Mirna, Laura Bäz, Nina Bacher, Albert Topf, Brigitte Sipos, Marcus Franz, Daniel Kretzschmar, Uta C Hoppe, Alexander Lauten, Michael Lichtenauer

Tumor necrosis factor alpha-an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?

肿瘤坏死因子 α——接受经导管主动脉瓣置换术(TAVR)的患者中被低估的风险预测因子?

Moritz Mirna, Mario Holnthoner, Albert Topf, Peter Jirak, Dzeneta Fejzic, Vera Paar, Jörg Kellermair, Hermann Blessberger, Christian Reiter, Jürgen Kammler, Lukas J Motloch, Christian Jung, Daniel Kretzschmar, Marcus Franz, Brunilda Alushi, Alexander Lauten, Uta C Hoppe, Clemens Steinwender, Michael

The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events

Fetuin-A 作为识别 Takotsubo 患者发生心血管事件风险的预测指标的价值

Albert Topf, Moritz Mirna, Nina Bacher, Vera Paar, Christoph Edlinger, Lukas J Motloch, Sarah Gharibeh, Marwin Bannehr, Uta C Hoppe, Michael Lichtenauer

Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-Study

慢性肾病患者的新型生物标志物:对参与 GCKD 研究的患者进行的分析

Moritz Mirna, Albert Topf, Bernhard Wernly, Richard Rezar, Vera Paar, Christian Jung, Hermann Salmhofer, Kristen Kopp, Uta C Hoppe, P Christian Schulze, Daniel Kretzschmar, Markus P Schneider, Ulla T Schultheiss, Claudia Sommerer, Katharina Paul, Gunter Wolf, Michael Lichtenauer, Martin Busch